why choose us

First received: June 04, 2024

Clinical Trial: Real-World Treatment Study of Soliris (Eculizumab)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Observational

Study Type: OBSERVATIONAL


Official Title: Real-World Treatment Study of Soliris (Eculizumab)

Brief Summary: As part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients who are treated with Soliris in normal clinical practice settings.This study is designed to assess the known safety profile or identify previously unsuspected adverse reactions and to evaluate the effectiveness of Soliris under conditions of routine daily medical practice in Korea.This study will provide information on the population of Korean patients who are treated with…

Read more